BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/21/2023 2:14:18 AM | Browse: 502 | Download: 1723
Publication Name World Journal of Clinical Oncology
Manuscript ID 85438
Country Italy
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Observational Study
Article Title Hyperthermia combined with chemotherapy vs chemotherapy in patients with advanced pancreatic cancer: A multicenter retrospective observational comparative study
Manuscript Source Unsolicited Manuscript
All Author List Giammaria Fiorentini, Donatella Sarti, Andrea Mambrini, Ivano Hammarberg Ferri, Massimo Bonucci, Paola Giordano Sciacca, Marco Ballerini, Salvatore Bonanno, Carlo Milandri, Roberto Nani, Stefano Guadagni, Patrizia Dentico and Caterina Fiorentini
ORCID
Author(s) ORCID Number
Giammaria Fiorentini http://orcid.org/0000-0002-5615-889X
Donatella Sarti http://orcid.org/0000-0002-8031-7846
Andrea Mambrini http://orcid.org/0000-0001-9736-4991
Carlo Milandri http://orcid.org/0000-0001-6932-8977
Roberto Nani http://orcid.org/0000-0002-0923-5151
Stefano Guadagni http://orcid.org/0000-0001-8525-084X
Caterina Fiorentini http://orcid.org/0000-0002-9346-1409
Funding Agency and Grant Number
Corresponding Author Giammaria Fiorentini, MD, Adjunct Professor, Chief Doctor, Director, Director, Integrative Oncology, Integrative Oncology Outpatient Clinic, Via dell'Indipendenza, 20, Bologna 40121, Italy. g.fiorentini@alice.it
Key Words Modulated electro hyperthermia; Locally advanced pancreatic tumor; Overall survival; Tumor response; Gemcitabine; Apoptosis; Immunogenic cell death
Core Tip Pancreatic cancer has very poor prognosis with a 5-year overall survival of 5% and a median overall survival (OS) time of 8-12 mo. The concomitant use of modulated electro-hyperthermia (mEHT) in addition to chemotherapy has been introduced. mEHT has specific antitumor effects, increasing survival and tumor response. This was a retrospective data collection on 217 patients affected by locally advanced pancreatic cancer performed in 9 Italian centres, aiming to assess survival, tumour response and toxicity. The mEHT group had a greater OS (20 mo vs 9 mo, P < 0.001), higher number of partial responses (45% vs 24%, P = 0.0018) and a lower number of progressions (4% vs 31%, P < 0.001) than no-mEHT group. Adverse events were observed in 2.6% of mEHT sessions. mEHT have beneficial effects on survival and tumor response of stage III-IV pancreatic tumor patients, without adding toxicity.
Publish Date 2023-06-21 02:14
Citation Fiorentini G, Sarti D, Mambrini A, Ferri IH, Bonucci M, Sciacca PG, Ballerini M, Bonanno S, Milandri C, Nani R, Guadagni S, Dentico P, Fiorentini C. Efficacy and safety of hyperthermia alone or in combination with chemotherapy vs chemotherapy in patients with advanced pancreatic cancer: A multicenter retrospective observational comparative study on 217 patients. World J Clin Oncol 2023; 14(6): 215-226
URL https://www.wjgnet.com/2218-4333/full/v14/i6/215.htm
DOI https://dx.doi.org/10.5306/wjco.v14.i6.215
Full Article (PDF) WJCO-14-215-with-cover.pdf
Full Article (Word) WJCO-14-215.docx